Literature DB >> 20973297

Diagnosis and management of cardiogenic pulmonary edema.

Idrus Alwi1.   

Abstract

Acute cardiogenic pulmonary edema (ACPE) is a common cardiogenic emergency with a quite high in-hospital mortality rate. ACPE is defined as pulmonary edema with increased secondary hydrostatic capillary pressure due to elevated pulmonary venous pressure. Increased hydrostatic pressure may result from various causes including excessive administration of intravascular volume, obstruction of pulmonary venous outflow or secondary left ventricular failure due to left ventricular systolic or diastolic dysfunction. ACPE must be distinguished from pulmonary edema associated with injury of alveolar capillary membrane caused by various etiologies, i.e. direct pulmonary injury such as pneumonia and indirect pulmonary injury such as sepsis. Numerous clinical manifestations may differentiate ACPE and Non-ACPE. ACPE usually presents with a history of acute cardiac catastrophe. Physical examination reveals a low-flow state, S3 gallop, jugular venous distention and fine crepitant rales with auscultation. The diagnosis of pulmonary edema is made based on symptoms and clinical signs are found through history taking, physical examination, ECG, chest X-ray, echocardiography and laboratory tests including blood gas analysis and specific biomarkers. Medical treatment of ACPE has 3 main objectives, i.e.: (1) reduced venous return (preload reduction); (2) reduced resistance of systemic vascular (afterload reduction); and (3) inotropic support in some cases. Treatment that can be administered includes: vasodilator when there is normal or high BP, diuretics when there is volume overload or fluid retention, and inotropic drugs when there is hypotension or signs of organ hypoperfusion. Intubation and mechanical ventilation may be necessary to achieve adequate oxygenation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20973297

Source DB:  PubMed          Journal:  Acta Med Indones        ISSN: 0125-9326


  2 in total

1.  Cystic Fibrosis Transmembrane Conductance Regulator Potentiation as a Therapeutic Strategy for Pulmonary Edema: A Proof-of-Concept Study in Pigs.

Authors:  Xiaopeng Li; Luis G Vargas Buonfiglio; Ryan J Adam; David A Stoltz; Joseph Zabner; Alejandro P Comellas
Journal:  Crit Care Med       Date:  2017-12       Impact factor: 7.598

2.  Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome.

Authors:  Fereshteh Ashtari; Rasool Soltani; Shervin Shokouhi; Ali Rismanbaf; Somayeh Hajiahmadi; Atousa Hakamifard
Journal:  Clin Case Rep       Date:  2021-07-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.